Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CYIG Registration revoked. No prior SEC Suspension or Admin. Proceeding.
https://www.sec.gov/litigation/admin/2020/34-89990.pdf
Calculations based on the current issued Quarterly Report ending Dec 31st 2019 on OTCMarkets, the PPS should be at least $3.84.
http://yct.yctgroup.com/en/index.html
The fact that this profitable company registered in Delaware but operating in China is so undervalued is a mystery to me.
https://backend.otcmarkets.com/otcapi/company/financial-report/240116/content
https://www.otcmarkets.com/stock/CYIG/disclosure
CYIG has been consistently profitable now for years, with a discounted cash flow value near $18, but it hasn't broken a dollar in stock price in years
I realize your post is now 5 years old, but you seemed to be familiar with the company back then, I'm curious to know where you stand these days
10Q out.
Net profit $ 5.4 million or .13 per share
Cash $15 million
Assets $ 94 million
Liabilities $ 1.4 million
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12232033
Aventador
I see no reason whatever for your expectation. This is a company with very low growth. SIAF can be expected to grow 10 times as fast as this Company is growing and is trading at a p/e about a third of this company.
CYIG(Symbol)seems appealing at current price level if its Acer Truncatum Program runs well in the future.Target@1.50
Breaking News! CYIG (Symbol) has held a conference with Nanjing Forestry University for cooperation plan, stepping onto the worldwide stage and embracing fast development. Tgt@$1.50
CYIG crashed with tiny volume before it released good financial results. Obviously, it just presented us with a very cheap entry point!Tgt@ 1.5
Making profits in a falling market depends on how you select the right stock!CYIG reached the bottom but other metrics are well!Tgt@1.5
CYIG could move ahead on positive annual earning report:Revenues and Total Profits both registered steady growth, with promising outlook,CYIG could see $1.50!
CYIG(Symbol)should climb above $6.0 as Price usually trades at 3 times Book value per share.According to book value per share of $2.21,its price should trade above $6.0.
CYIG(Symbol)is a "SUPER STOCK" which once rocketed from $0.003 to $2.84 within a day. It will rebound to 52-week high @2.84 due to four reasons.
CYIG(symbol)+32% after the debut alert and now the explosive second-round run kicking off!P/E only 3.26 reflects CYIG’s undervalued situation!Tgt @2.84
All plans that CYIG(symbol)commenced will start to pay off very quickly!These are the intrinsic values of CYIG that drive the stock go higher!Tgt @52-wk high
CYIG(Symbol) would surge higher for its positive industry outlook and various product lines!After 94500% one-day gain,CYIG now may deliver another perfect return!Target@2.84
CYIG(Symbol) could be perfect start to June as its new acer truncatum project may gain gov. policy support and easily access to funds!Once above $1.0,see target@2.84!
Huge Profits low share structure undervalued
All my thoughts only,
LM
WHAT'S YOUR TAKE, ON IT?
Earnings are up 5.6 Percent. I am guessing the price will also go up up and away.
Beats the hell out of me. I still check on it, from time to time, but unless it drops back down to a few dimes or pennies, I will not get into this one.
It is because the company has done absolutely nothing since that record breaking pump. Really a shame since they really could have made some sustained gains had they presented anything of value during the promo....... Didn't get any help from the company.... WHY??
This stock is trading below liquidation value. Early this year, there was a "pump," but no real "dump." Good fundamental value, but the stock price does not reflect it. I don't know why. I am not in this stock.
I WONT BE SURPRISED IF THIS HITS $2 BY WEDNESDAY, THIS WEEK!!!
THIS IS ABOUT TO FLY !!....from my past experience, this moves BIG TIME, with very little notice !!!
I think it goes up to about 2 dollars depending on how much volume. The more volume the higher it will shoot very few shares are avaiable....
I AGREE !!....This is about to "MAKE BANK!"
Holly snaps is that a great recent quarter result or what?!
10K just out for CYIG. Big earnings. Hopefully it will run.
Someone is nibbling today in CYIG. Hopefully the downtrend is broken.
From .003 to $2.84
Still some serious gains even here
IMO
As soon as it comes out, I will read it too.
I was referring to the strong balance sheet, which would warrant a higher PPS.
Yeah, what a sham dame...it's only double what it was yesterday. Something terribly wrong here?
I wonder why this stock is trading so low. Any thoughts? TIA...
Post any sort of proof of your claim. Running around talking "rumor" is the oldest con on the hub.
I'll wait for the link.
Followers
|
27
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
895
|
Created
|
08/16/07
|
Type
|
Free
|
Moderators |
1. China YCT Inc has over 280 employees & a Low Float
2. Current Market Cap is only $88,000... Yes! you read that right eighty-eight thousand dollars!
3. Revenues: 9 months ending December, 2012 were over $23.5 million
4. Net Income: 9 months ending December, 2012 were over $13 million a 528.5% INCREASE over net income for the same period in 2011!
5. Over $27.3 Million in CASH on it's balance sheet!
6. Total Assets of over $57.5 Million with just $2.4 million of liabilities
CYIG through its subsidiaries, engages in developing, manufacturing, and marketing gingko and other dietary supplement products in the Peoples Republic of China. It provides Huoliyuan capsule for the treatment of chronic hepatitis, diabetes, insomnia, memory loss, menopause syndrome, and other maladies. The company also offers 10 health care supplement products. It markets its products through a network of dealers. The company is based in Sishui County, the Peoples Republic of China.
CYIG has become a high-tech, international enterprise specializing in the Research and Development (R&D), production and sales of Gingko nutraceutical health products. The Company continually enhances its market competitiveness and competitive advantages through scientific and technological innovation.
CYIG is devoted to the goal of a healthy lifestyle for the Chinese people as seen in its:
Enterprise mission: To share healthy living and lead development in the gingko industry
Enterprise spirit: To constantly strive for self-improvement through hard work, dedication, wisdom, creativity and innovation
Enterprise target: To build an international YongChunTang brand
http://www.yongchuntang.com.hk/index.html
http://www.faqs.org/sec-filings/110909/China-YCT-International-Group-Inc_10-K/v234286_ex10-2.htm
Presently, CYIG has over 30 branches in China, as well as a branch in Russia, and more than 300 distributors. Working toward globalization, the Company has built a strong base with its domestic supply chain and sales network while actively pursuing an international development strategy to expand CYIG's products and services in the international market. CYIG is a dynamic, thriving enterprise that is leading China's nutraceutical industry into the future by giving investors and society the highest level of returns.
Products
Ginkgo Biloba is an herb that has been used medicinally for thousands of years. A fundamental ingredient in most Traditional Chinese Medicine, Ginkgo is now one of the top selling herbs in the US. Ginkgo is also one of the most well researched herbs in the world and is currently under scientific study for the treatment of many illnesses. Studies have already shown that Gingko supports healthy circulation to both the brain and extremities of the body by increasing blood flow and decreasing the viscosity of blood. Improved brain circulation has also been tied to improved cognitive function, specifically increased mental sharpness and decreased mild memory problems associated with age. Ginkgo also provides antioxidant properties that help fight cell-damaging free radicals in the body. Overall, Ginkgo is a popular herb that is well tolerated and widely used for medicinal purposes and new uses are being discovered every day.
CYIG currently has a full line of Ginkgo Biloba products from healthy foods, nutritial foods, health supplies, cosmetics, & commodity items.
Innovation Through Research & Development
CYIG leverages R&D to create a competitive advantage through improved product technology and reduced costs. CYIG appropriates 2.5-3% of sales to R&D expenditures and special inventive measures for technological achievements.
In August 2005, the Company acquired China Shandong Spring Pharmaceutical Co., Ltd., a modern high-tech pharmaceutical manufacturing enterprise in Shandong Province, Jining City. Shandong specializes in the R&D and production of nutraceutical health products, tablets, capsules, and thrombolytic injections. It has two major R&D institutions - Shandong Province Enterprise Technology Center and Shandong Province Ginkgo Engineering Research Center - that are equipped with advanced production and processing equipment and world-class testing equipment for quality control, ensuring all products meet international quality standards and requirements.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |